releases: https://doggett.house.gov/media-center/press-releases/more-trump-doubletalk-drug-prices

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url	title	date	year	month	party	chamber	state	member_name	bioguide_id	domain	scraper	source	date_source	text	has_text	collected_at	updated_at
https://doggett.house.gov/media-center/press-releases/more-trump-doubletalk-drug-prices	More Trump Doubletalk on Drug Prices	2020-11-20	2020	2020-11	Democrat	Senate	TX	Lloyd Doggett	D000399	doggett.house.gov			legacy	*For Immediate Release* FOR IMMEDIATE RELEASE November 20, 2020 Contact:Kate Stotesbery 202-494-4620 More Trump Doubletalk on Drug Prices Washington, D.C. This afternoon, U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways & Means Health Subcommittee, released this statement immediately following President Trump's remarks regarding drug pricing measures: Today's announcement offers little more relief from soaring prescription prices than Trump's September announcement of $200 drug cards, which he never delivered. By delaying until the end of his Presidency taking action he could have undertaken at the beginning, Trump offers an invitation to legal challengesnot a guarantee of relief from price gouging. And the most important order remains missing: lower prices for drugs developed with taxpayer dollars, including COVID-19 treatments and vaccines. Trump is a loser not only in this election, but in failing for his entire presidency to lower drug prices for anyone. One positive signal from Trump's misleading announcement is to President-elect Biden, who is clearly empowered to take effective administrative action to actually lower drug prices for many next year. ### Follow Congressman Doggett Facebook:https://www.Facebook.com/RepLloydDoggett \| Twitter: @RepLloydDoggett\| Instagram: @RepLloydDoggett	1	2026-03-30T12:14:52Z	2026-03-30T12:14:52Z